Bausch Health Companies Inc (BHC) - Total Assets
Based on the latest financial reports, Bausch Health Companies Inc (BHC) holds total assets worth CA$24.50 Billion CAD (≈ $17.72 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore BHC debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Bausch Health Companies Inc - Total Assets Trend (1993–2025)
This chart illustrates how Bausch Health Companies Inc's total assets have evolved over time, based on quarterly financial data. See Bausch Health Companies Inc net assets for net asset value and shareholders' equity analysis.
Bausch Health Companies Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Bausch Health Companies Inc's total assets of CA$24.50 Billion consist of 23.4% current assets and 76.7% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$1.31 Billion | 5.0% |
| Accounts Receivable | CA$2.35 Billion | 8.9% |
| Inventory | CA$1.63 Billion | 6.2% |
| Property, Plant & Equipment | CA$2.29 Billion | 8.7% |
| Intangible Assets | CA$4.63 Billion | 17.6% |
| Goodwill | CA$11.25 Billion | 42.8% |
Asset Composition Trend (1993–2025)
This chart illustrates how Bausch Health Companies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Bausch Health Companies Inc (BHC) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bausch Health Companies Inc's current assets represent 23.4% of total assets in 2025, a decrease from 29.2% in 1993.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 11.6% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 4.0% in 1993.
- Asset Diversification: The largest asset category is goodwill at 42.8% of total assets.
Bausch Health Companies Inc Competitors by Total Assets
Key competitors of Bausch Health Companies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
|
China | CN¥6.49 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
|
China | CN¥7.28 Billion |
|
Celltrion Pharm Inc
KQ:068760
|
Korea | ₩745.80 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Heilongjiang ZBD Pharmaceutical Co Ltd
SHG:603567
|
China | CN¥11.80 Billion |
|
Zhejiang Anglikang Pharmaceutical Co Ltd Class A
SHE:002940
|
China | CN¥3.12 Billion |
Bausch Health Companies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.32 | 1.35 | 0.99 |
| Quick Ratio | 0.97 | 0.97 | 0.79 |
| Cash Ratio | 0.00 | 0.27 | 0.12 |
| Working Capital | CA$1.45 Billion | CA$1.48 Billion | CA$-67.00 Million |
Bausch Health Companies Inc - Advanced Valuation Insights
This section examines the relationship between Bausch Health Companies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 18.74 |
| Latest Market Cap to Assets Ratio | 0.10 |
| Asset Growth Rate (YoY) | -0.8% |
| Total Assets | CA$26.32 Billion |
| Market Capitalization | $2.61 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Bausch Health Companies Inc's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Bausch Health Companies Inc's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Bausch Health Companies Inc (1993–2025)
The table below shows the annual total assets of Bausch Health Companies Inc from 1993 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CA$26.32 Billion ≈ $19.04 Billion |
-0.77% |
| 2024-12-31 | CA$26.52 Billion ≈ $19.19 Billion |
-3.02% |
| 2023-12-31 | CA$27.35 Billion ≈ $19.78 Billion |
+6.48% |
| 2022-12-31 | CA$25.69 Billion ≈ $18.58 Billion |
-12.04% |
| 2021-12-31 | CA$29.20 Billion ≈ $21.12 Billion |
-6.40% |
| 2020-12-31 | CA$31.20 Billion ≈ $22.57 Billion |
-7.87% |
| 2019-12-31 | CA$33.86 Billion ≈ $24.50 Billion |
+23.38% |
| 2018-12-31 | CA$27.45 Billion ≈ $19.85 Billion |
-26.80% |
| 2017-12-31 | CA$37.50 Billion ≈ $27.12 Billion |
-13.86% |
| 2016-12-31 | CA$43.53 Billion ≈ $31.49 Billion |
-11.10% |
| 2015-12-31 | CA$48.96 Billion ≈ $35.42 Billion |
+85.80% |
| 2014-12-31 | CA$26.35 Billion ≈ $19.06 Billion |
-5.78% |
| 2013-12-31 | CA$27.97 Billion ≈ $20.23 Billion |
+55.82% |
| 2012-12-31 | CA$17.95 Billion ≈ $12.99 Billion |
+36.59% |
| 2011-12-31 | CA$13.14 Billion ≈ $9.51 Billion |
+21.74% |
| 2010-12-31 | CA$10.80 Billion ≈ $7.81 Billion |
+422.25% |
| 2009-12-31 | CA$2.07 Billion ≈ $1.50 Billion |
+27.32% |
| 2008-12-31 | CA$1.62 Billion ≈ $1.17 Billion |
-8.90% |
| 2007-12-31 | CA$1.78 Billion ≈ $1.29 Billion |
-18.06% |
| 2006-12-31 | CA$2.18 Billion ≈ $1.57 Billion |
-0.60% |
| 2005-12-31 | CA$2.19 Billion ≈ $1.58 Billion |
+8.74% |
| 2004-12-31 | CA$2.01 Billion ≈ $1.46 Billion |
+4.65% |
| 2003-12-31 | CA$1.92 Billion ≈ $1.39 Billion |
+4.85% |
| 2002-12-31 | CA$1.83 Billion ≈ $1.33 Billion |
+37.73% |
| 2001-12-31 | CA$1.33 Billion ≈ $963.17 Million |
+20.25% |
| 2000-12-31 | CA$1.11 Billion ≈ $800.98 Million |
+74.35% |
| 1999-12-31 | CA$635.10 Million ≈ $459.42 Million |
+217.71% |
| 1998-12-31 | CA$199.90 Million ≈ $144.60 Million |
+113.34% |
| 1997-12-31 | CA$93.70 Million ≈ $67.78 Million |
+59.90% |
| 1996-12-31 | CA$58.60 Million ≈ $42.39 Million |
-3.78% |
| 1995-12-31 | CA$60.90 Million ≈ $44.05 Million |
+137.89% |
| 1994-12-31 | CA$25.60 Million ≈ $18.52 Million |
+9.87% |
| 1993-12-31 | CA$23.30 Million ≈ $16.85 Million |
-- |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more